Shane White

Phase 1b study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (Atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (aTNBC)

P Schmid, S Kuemmel, D Loirat, P Savas, E Espinosa, V Boni, A Italiano, S White, S Singel, N Withana, A Mani, S Li, A Harris, M Wongchenko, M Sablin

Conference Proceedings  |  2020  |  GEBURTSHILFE UND FRAUENHEILKUNDE

Durvalumab induced sarcoid-like pulmonary lymphadenopathy

Emma Sanderson, Hari Wimaleswaran, Clare Senko, Shane White, Christine F McDonald

Journal article  |  2020  |  Respirology Case Reports

Immune checkpoint inhibitors (ICIs) have become pivotal in the treatment of lung cancer. An increasing number of immune-related ad..

P2.04-11 Overcoming Resistance to Immunotherapy Using CVA21: Initial Results from a Phase II Study

C Senko, M Klevansky, G Peters, P Mitchell, S White, S Arulananda, A Zimet, K Asadi, J Smith, N Micaleff, J Palmer, T Morgan, O Klein, J Cebon, T John

Conference Proceedings  |  2019  |  Journal of Thoracic Oncology

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable

L Chin-Lenn, RH De Boer, E Segelov, GM Marx, TM Hughes, NJ McCarthy, SC White, SS Foo, JJ Rutovitz, S Della-Fiorentina, R Jennens, YC Antill, D Tsoi, MF Cronk, JM Lombard, BE Kiely, JH Chirgwin, A Gorelik, GB Mann

Journal article  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

OBJECTIVES: Industry-supported decision impact studies demonstrate that Oncotype Dx (ODX) changes treatment recommendations (TR) i..

Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors

Susan R Davis, Penelope J Robinson, Fiona Jane, Shane White, Michelle White, Robin J Bell

Journal article  |  2018  |  JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Context: Intravaginal testosterone (IVT) is a potential treatment of vulvovaginal atrophy (VVA) associated with aromatase inhibito..

The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial

Susan R Davis, Penelope J Robinson, Fiona Jane, Shane White, Kristy A Brown, Sofie Piessens, Andrew Edwards, Jane McNeilage, Jillian Woinarski, Mitchell Chipman, Robin J Bell

Journal article  |  2018  |  CLINICAL ENDOCRINOLOGY

BACKGROUND: We investigated whether metformin prevents tamoxifen-induced endometrial changes and insulin resistance (IR) after a d..

Culturally and linguistically diverse oncology patients' perspectives of consultation audio-recordings and question prompt lists

Amelia Hyatt, Ruby Lipson-Smith, Karla Gough, Phyllis Butow, Michael Jefford, Thomas F Hack, Sandra Hale, Emiliano Zucchi, Shane White, Uldis Ozolins, Penelope Schofield

Journal article  |  2018  |  PSYCHO-ONCOLOGY

OBJECTIVE: Ethnicity and migrant status result in disparities with cancer burden and survival, with communication difficulties cit..

Exploring disparities in receipt of adjuvant chemotherapy in culturally and linguistically diverse groups: an Australian centre's experience

Alesha A Thai, Mark Tacey, Amanda Byrne, Shane White, Jaclyn Yoong

Journal article  |  2018  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Globally, racial and ethnic disparities exist in treatments and outcomes for cancer patients. In Australia, there are ..

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson, Jacquie Chirgwin, Stefan Aebi, Guy Jerusalem, Patrick Neven, Erika Hitre, Marie-Pascale Graas, Edda Simoncini, Claus Kamby, Alastair Thompson, Sibylle Loibl, Joaquin Gavila, Katsumasa Kuroi, Christian Marth, Bettina Mueller, Seamus O'Reilly, Vincenzo Di Lauro, Andrea Gombos, et al.

Journal article  |  2018  |  LANCET ONCOLOGY

BACKGROUND: In animal models of breast cancer, resistance to continuous use of letrozole can be reversed by withdrawal and reintro..

Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice

M Alexander, R Blum, K Burbury, J Coutsouvelis, M Dooley, O Fazil, T Griffiths, H Ismail, S Joshi, N Love, S Opat, P Parente, N Porter, E Ross, J Siderov, P Thomas, S White, S Kirsa, D Rischin

Journal article  |  2017  |  INTERNAL MEDICINE JOURNAL

This review evaluated the association between time-to-chemotherapy (TTC) and survival in six priority cancers. A systematic review..